ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 36 filers reported holding ESSA PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,930 | -23.2% | 29,427 | -32.9% | 0.00% | – |
| Q2 2023 | $118,457 | -33.1% | 43,873 | -26.5% | 0.00% | – |
| Q1 2023 | $177,000 | +804445.5% | 59,706 | +582.3% | 0.00% | – |
| Q4 2022 | $22 | -100.0% | 8,751 | -88.1% | 0.00% | – |
| Q3 2022 | $134,000 | -84.8% | 73,668 | -73.7% | 0.00% | – |
| Q2 2022 | $882,000 | +86.1% | 279,725 | +264.5% | 0.00% | – |
| Q1 2022 | $474,000 | +134.7% | 76,750 | +440.8% | 0.00% | – |
| Q4 2021 | $202,000 | +80.4% | 14,192 | +1.4% | 0.00% | – |
| Q3 2021 | $112,000 | +148.9% | 13,993 | +787.9% | 0.00% | – |
| Q2 2021 | $45,000 | +25.0% | 1,576 | +27.4% | 0.00% | – |
| Q1 2021 | $36,000 | +157.1% | 1,237 | +7.4% | 0.00% | – |
| Q4 2020 | $14,000 | -58.8% | 1,152 | -76.6% | 0.00% | – |
| Q3 2020 | $34,000 | – | 4,927 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |